Bristol-Myers reports negative results from Phase III study of Opdivo
Bristol-Myers Squibb Company has reported negative results from the Phase III CheckMate -331 trial of Opdivo. The trial examined Opdivo…
SCLC Bristol-Myers Squibb Company
